Search

everythinglearnresearchcommunity

for

Search:↓

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

PRP shows promise for treating female hair loss but needs more research.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Stress can trigger and worsen vitiligo.

PBMCsec can help reduce and improve thick skin scars.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

Genetic discoveries are leading to new treatments for alopecia areata.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Diet and supplements can significantly affect acne, with some foods and nutrients reducing and others worsening it.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

PCOS may increase the risk of certain cancers.

No link found between specific genes and female pattern hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.